MEAGAN GRAY: Open Payments
NPI 1457613580 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$31,015 in 28 payments from 4 companies in 2025. Trend: 2023 $8,621 · 2024 $27,885 · 2025 $31,015
Consulting: $28,770Travel & lodging: $1,262Food & beverage: $983
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $12,261 |
| Novo Nordisk Inc | 6 | $10,778 |
| Madrigal Pharmaceuticals | 10 | $7,810 |
| Gilead Sciences, Inc. | 3 | $166 |
Products named: REZDIFFRA, Wegovy.
Industry payments across AL — which companies pay providers there.
